Esperante is a venture investment company controlled by C&P Group Holdings, a privately controlled life science interests group. The management, Board of Directors, Investment Committee and Advisors are significantly experienced in the operational management of life science companies, with a particular focus on the development, manufacturing and marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests on a worldwide basis.
Highly differentiated drug developments, particularly in orphan indications, in or entering Phase II clinical development with established human proof of concept and safety.
Highly differentiated in vitro diagnostic and biomarker tests for major clinical indications and available as a deliverable ELISA or multiplex platform kit, or in point of care form.
Pharmaceutical sales companies operating in at least one major market with strongly differentiated products in specialist therapeutic indications.